Archived Facts

A one-year study of an experimental diabetes drug made by Bristol-Myers Squibb and AstraZeneca PLC showed it was no worse at controlling blood sugar levels than an older drug called glipizide, the companies said Friday.

View full post on All News, Video and Posts related to SECTOR: Health Care

Popular Posts:

Related Posts:

Leave a Reply